
Paul M. Rivard
Examiner (ID: 3272)
| Most Active Art Unit | 1304 |
| Art Unit(s) | 2899, 1304, 1734 |
| Total Applications | 355 |
| Issued Applications | 271 |
| Pending Applications | 27 |
| Abandoned Applications | 57 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19447188
[patent_doc_number] => 20240307318
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-19
[patent_title] => COMPOSITIONS AND USES THEREOF IN TREATING CANCERS
[patent_app_type] => utility
[patent_app_number] => 18/185630
[patent_app_country] => US
[patent_app_date] => 2023-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8571
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18185630
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/185630 | COMPOSITIONS AND USES THEREOF IN TREATING CANCERS | Mar 16, 2023 | Pending |
Array
(
[id] => 20262934
[patent_doc_number] => 12433902
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-10-07
[patent_title] => Liposomal formulations for inhibiting SARS-CoV-2 replication and reducing lung inflammation
[patent_app_type] => utility
[patent_app_number] => 18/120770
[patent_app_country] => US
[patent_app_date] => 2023-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 16808
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18120770
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/120770 | Liposomal formulations for inhibiting SARS-CoV-2 replication and reducing lung inflammation | Mar 12, 2023 | Issued |
Array
(
[id] => 20262934
[patent_doc_number] => 12433902
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-10-07
[patent_title] => Liposomal formulations for inhibiting SARS-CoV-2 replication and reducing lung inflammation
[patent_app_type] => utility
[patent_app_number] => 18/120770
[patent_app_country] => US
[patent_app_date] => 2023-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 16808
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18120770
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/120770 | Liposomal formulations for inhibiting SARS-CoV-2 replication and reducing lung inflammation | Mar 12, 2023 | Issued |
Array
(
[id] => 18483691
[patent_doc_number] => 20230210993
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-06
[patent_title] => LIPID COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 18/182733
[patent_app_country] => US
[patent_app_date] => 2023-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10180
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 462
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18182733
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/182733 | LIPID COMPOSITION | Mar 12, 2023 | Pending |
Array
(
[id] => 20262934
[patent_doc_number] => 12433902
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-10-07
[patent_title] => Liposomal formulations for inhibiting SARS-CoV-2 replication and reducing lung inflammation
[patent_app_type] => utility
[patent_app_number] => 18/120770
[patent_app_country] => US
[patent_app_date] => 2023-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 16808
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18120770
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/120770 | Liposomal formulations for inhibiting SARS-CoV-2 replication and reducing lung inflammation | Mar 12, 2023 | Issued |
Array
(
[id] => 19185464
[patent_doc_number] => 20240164377
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-23
[patent_title] => LOW VOLATILITY PROMOTING WATER CONDITIONING ADJUVANTS
[patent_app_type] => utility
[patent_app_number] => 18/180656
[patent_app_country] => US
[patent_app_date] => 2023-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5689
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18180656
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/180656 | LOW VOLATILITY PROMOTING WATER CONDITIONING ADJUVANTS | Mar 7, 2023 | Abandoned |
Array
(
[id] => 18510092
[patent_doc_number] => 20230226192
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-20
[patent_title] => IONIZABLE LIPIDS AND COMPOSITIONS FOR NUCLEIC ACID DELIVERY
[patent_app_type] => utility
[patent_app_number] => 18/117049
[patent_app_country] => US
[patent_app_date] => 2023-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13256
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18117049
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/117049 | Ionizable lipids and compositions for nucleic acid delivery | Mar 2, 2023 | Issued |
Array
(
[id] => 18536004
[patent_doc_number] => 20230241091
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-03
[patent_title] => COMPOSITIONS FOR USE IN THE TREATMENT AND PREVENTION OF CARDIOVASCULAR DISORDERS RESULTING FROM CEREBROVASCULAR INJURY
[patent_app_type] => utility
[patent_app_number] => 18/173980
[patent_app_country] => US
[patent_app_date] => 2023-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27037
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18173980
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/173980 | Compositions for use in the treatment and prevention of cardiovascular disorders resulting from cerebrovascular injury | Feb 23, 2023 | Issued |
| 18/041891 | LIPID DELIVERY SYSTEMS FOR DELIVERY OF OXALIPLATIN PALMITATE ACETATE | Feb 15, 2023 | Abandoned |
Array
(
[id] => 19359217
[patent_doc_number] => 20240261251
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-08
[patent_title] => Composition for Liposomal Delivery of Supplemental Urolithin
[patent_app_type] => utility
[patent_app_number] => 18/166335
[patent_app_country] => US
[patent_app_date] => 2023-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3770
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18166335
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/166335 | Composition for Liposomal Delivery of Supplemental Urolithin | Feb 7, 2023 | Pending |
Array
(
[id] => 19359217
[patent_doc_number] => 20240261251
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-08
[patent_title] => Composition for Liposomal Delivery of Supplemental Urolithin
[patent_app_type] => utility
[patent_app_number] => 18/166335
[patent_app_country] => US
[patent_app_date] => 2023-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3770
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18166335
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/166335 | Composition for Liposomal Delivery of Supplemental Urolithin | Feb 7, 2023 | Pending |
Array
(
[id] => 19359217
[patent_doc_number] => 20240261251
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-08
[patent_title] => Composition for Liposomal Delivery of Supplemental Urolithin
[patent_app_type] => utility
[patent_app_number] => 18/166335
[patent_app_country] => US
[patent_app_date] => 2023-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3770
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18166335
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/166335 | Composition for Liposomal Delivery of Supplemental Urolithin | Feb 7, 2023 | Pending |
Array
(
[id] => 18434185
[patent_doc_number] => 20230181479
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-15
[patent_title] => POLYMER BASED FORMULATION FOR RELEASE OF DRUGS AND BIOACTIVES AT SPECIFIC GIT SITES
[patent_app_type] => utility
[patent_app_number] => 18/164174
[patent_app_country] => US
[patent_app_date] => 2023-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4684
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18164174
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/164174 | POLYMER BASED FORMULATION FOR RELEASE OF DRUGS AND BIOACTIVES AT SPECIFIC GIT SITES | Feb 2, 2023 | Abandoned |
Array
(
[id] => 18550850
[patent_doc_number] => 20230248850
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-10
[patent_title] => GOLD MOLECULAR CLUSTERS AND METHODS OF USING SAME FOR NEAR-INFRARED IMAGING
[patent_app_type] => utility
[patent_app_number] => 18/102623
[patent_app_country] => US
[patent_app_date] => 2023-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16892
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18102623
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/102623 | GOLD MOLECULAR CLUSTERS AND METHODS OF USING SAME FOR NEAR-INFRARED IMAGING | Jan 26, 2023 | Pending |
Array
(
[id] => 19372972
[patent_doc_number] => 12064511
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-08-20
[patent_title] => Lipid nanoparticles containing silyl lipids for use in vaccines and gene therapy
[patent_app_type] => utility
[patent_app_number] => 18/159010
[patent_app_country] => US
[patent_app_date] => 2023-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 13
[patent_no_of_words] => 9284
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 123
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18159010
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/159010 | Lipid nanoparticles containing silyl lipids for use in vaccines and gene therapy | Jan 23, 2023 | Issued |
Array
(
[id] => 19246607
[patent_doc_number] => 20240197591
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-20
[patent_title] => COMPOSITIONS AND METHODS FOR REMOVING COLOR FROM HAIR
[patent_app_type] => utility
[patent_app_number] => 18/084403
[patent_app_country] => US
[patent_app_date] => 2022-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11970
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18084403
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/084403 | COMPOSITIONS AND METHODS FOR REMOVING COLOR FROM HAIR | Dec 18, 2022 | Pending |
Array
(
[id] => 19246607
[patent_doc_number] => 20240197591
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-20
[patent_title] => COMPOSITIONS AND METHODS FOR REMOVING COLOR FROM HAIR
[patent_app_type] => utility
[patent_app_number] => 18/084403
[patent_app_country] => US
[patent_app_date] => 2022-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11970
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18084403
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/084403 | COMPOSITIONS AND METHODS FOR REMOVING COLOR FROM HAIR | Dec 18, 2022 | Pending |
Array
(
[id] => 20127960
[patent_doc_number] => 12370260
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-07-29
[patent_title] => Supramolecular hydrogel for lipophilic drug delivery, a preparation method therefor, and use thereof
[patent_app_type] => utility
[patent_app_number] => 18/718353
[patent_app_country] => US
[patent_app_date] => 2022-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 13
[patent_no_of_words] => 0
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18718353
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/718353 | Supramolecular hydrogel for lipophilic drug delivery, a preparation method therefor, and use thereof | Dec 12, 2022 | Issued |
Array
(
[id] => 18690941
[patent_doc_number] => 20230321112
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-12
[patent_title] => CORTICOTROPIN RELEASING FACTOR RECEPTOR ANTAGONISTS
[patent_app_type] => utility
[patent_app_number] => 18/078649
[patent_app_country] => US
[patent_app_date] => 2022-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21523
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18078649
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/078649 | CORTICOTROPIN RELEASING FACTOR RECEPTOR ANTAGONISTS | Dec 8, 2022 | Pending |
Array
(
[id] => 18610858
[patent_doc_number] => 20230277588
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-07
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING PAIN WITH EXTRACELLULAR VESICLES
[patent_app_type] => utility
[patent_app_number] => 18/063227
[patent_app_country] => US
[patent_app_date] => 2022-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11375
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18063227
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/063227 | Compositions and methods for treating pain with extracellular vesicles | Dec 7, 2022 | Issued |